(Q50930614)

25 March 2018

title

Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya. (English)

1 reference

25 March 2018

1 reference

Ong'uti MN

1

1 reference

25 March 2018

Cruchley AT

series ordinal

2

1 reference

25 March 2018

Howells GL

series ordinal

3

1 reference

25 March 2018

Williams DM

series ordinal

4

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

25 March 2018

International Journal of Oral and Maxillofacial Surgery

published in

1 reference

25 March 2018

volume

26

1 reference

25 March 2018

issue

5

1 reference

25 March 2018

page(s)

376-379

1 reference

25 March 2018

Ameloblastoma: clinical features and management of 315 cases from Kaduna, Nigeria

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Labeling index in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Monoclonal antibody Ki-67: its use in histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

The labelling index: a prognostic factor in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

The treatment of ameloblastoma based on pathologic and anatomic principles

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

The complexities of proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Unicystic ameloblastoma: a prognostically distinct entity

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Proceedings: Ameloblastoma of maxilla and mandible

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

Prognostic evaluation of ameloblastoma based on histologic and radiographic typing

1 reference

https://api.crossref.org/works/10.1016%2FS0901-5027%2897%2980801-6

7 January 2021

10.1016/S0901-5027(97)80801-6

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018